Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran.

Keyphrases

• Arterial Ischemic Events 33%
• Direct Thrombin Inhibitors 33%
• Disease Foci 100%
• Dual Antiplatelet Therapy 33%
• High-risk Coronary Artery Disease 33%
• Long-term Treatment 33%
• Oral Anticoagulants 100%
• Oral Anticoagulation 33%
• P2Y12 Inhibitors 33%
• Pharmacologic Management 33%
• Thromboembolism 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Coronary Syndrome 33%
• Antiplatelet 33%
• Purinergic P2Y12 Receptor 33%
• Thrombin Inhibitor 33%